Amlodipine aspartic acid impurity is the impurity of Amlodipine aspartic acid. Amlodipine aspartic acid is a calcium channel blocker with antihypertensive and antianginal properties.
Amlodipine aspartic acid impurity is a specialized reference compound that arises as a process-related or degradation product during the synthesis or storage of amlodipine formulations. Structurally, it represents a conjugate or adduct between amlodipine—a widely studied dihydropyridine calcium channel blocker—and aspartic acid, an endogenous amino acid. The presence of such impurities is of significant interest in pharmaceutical research and quality control, as their detection, quantification, and characterization are critical for ensuring the safety and efficacy of drug substances. Its relevance extends to analytical method development, impurity profiling, and stability testing within the context of small molecule pharmaceuticals.
Impurity profiling: In pharmaceutical development, the identification and quantification of related substances such as the amlodipine aspartic acid impurity are essential for comprehensive impurity profiling. This compound serves as a crucial reference standard for validating analytical methods such as high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS). By enabling precise detection and measurement, it supports compliance with regulatory expectations for impurity characterization, allowing researchers to differentiate between the active pharmaceutical ingredient (API) and its structurally related byproducts.
Analytical method development: The availability of authentic reference materials like the amlodipine aspartic acid impurity is indispensable for developing and optimizing robust analytical techniques. Researchers utilize this impurity to assess the specificity, sensitivity, and reproducibility of chromatographic or spectrometric methods. Its inclusion in method validation studies ensures that analytical protocols can reliably identify and quantify trace levels of process impurities, thus enhancing the accuracy and reliability of pharmaceutical quality assessments.
Stability studies: Monitoring the formation of degradation products such as the amlodipine aspartic acid impurity is a central component of pharmaceutical stability testing. Under various stress conditions—such as heat, humidity, light, or pH changes—amlodipine formulations may generate impurities through chemical reactions with excipients, including amino acids. Tracking the presence and concentration of this specific impurity provides valuable insights into the degradation pathways and long-term stability of drug substances, supporting the establishment of appropriate shelf-life and storage recommendations.
Process optimization: The occurrence of amlodipine aspartic acid impurity during synthesis or formulation can inform process optimization efforts in pharmaceutical manufacturing. By studying the conditions that favor its formation, chemists and process engineers can identify critical control points and modify synthetic routes, purification steps, or formulation parameters to minimize impurity levels. This targeted approach not only improves product quality but also supports compliance with stringent regulatory limits on related substances.
Toxicological evaluation: Although present at low levels, impurities such as the amlodipine aspartic acid adduct warrant toxicological assessment to determine their safety profile. Reference materials facilitate in vitro and in silico studies that evaluate potential biological effects, metabolic fate, or interactions with drug targets. Such investigations are vital for risk assessment and for establishing acceptable daily intake thresholds, ultimately contributing to the overall safety evaluation of pharmaceutical products containing amlodipine.
1. Emu oil in combination with other active ingredients for treating skin imperfections
4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More